CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash Flows from Operating Activities:
Net loss	$ (5,523)	$ (13,172)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	13,791	7,362
Change in fair value of contingent consideration	(211)
Change in fair value of embedded derivative		306
Change in fair value of warrant liabilities	(39,215)
Loss on extinguishment of debt	13,225
Amortization of debt issuance costs	8,540	1,089
Equity-based compensation	3,239	112
Paid in kind interest expense		1,188
Changes in operating assets and liabilities:
Accounts receivable, net	(54,973)	(17,806)
Inventory	(254)	(273)
Other assets	(5,925)	(20)
Prepaid expenses and other current assets	(16,790)	(268)
Accounts payable and accrued expenses (Related parties comprised $123 and $(52) as of June 30, 2021 and 2020, respectively)	23,407	9,033
Deferred rent (Related parties comprised $115 as of June 30, 2021)	1,757	564
Deferred revenue (Related parties comprised $671 as of June 30, 2021)	671
Other liabilities (Related parties comprised $456 as of June 30, 2021)	1,681	(1,258)
Net cash used in operating activities	(56,580)	(13,143)
Cash Flows from Investing Activities:
Purchase of property and equipment (Related parties comprised $2,864 and $1,025 as of June 30, 2021 and 2020, respectively)	(7,730)	(3,971)
Acquisitions of subsidiaries including non-compete intangibles, net of cash acquired	(617,576)	(205,325)
Payments to sellers	(23,963)	(36,628)
Advances to related parties		(2)
Net cash used in investing activities	(649,269)	(245,926)
Cash Flows from Financing Activities:
Contributions from member		101,906
Business combination and PIPE financing	935,362
Interest accrued due to sellers	957
Payments of long-term debt	(402,572)	(338)
Debt issuance costs	(11,274)	(11,356)
Proceeds from long-term debt	295,000	150,000
Proceeds from delayed draw term loan	175,000
Repayments of delayed draw term loan	(2,350)
Proceeds from revolving credit facility		9,700
Repayments of revolving credit facility		(9,700)
Proceeds from insurance financing arrangements	4,355	2,599
Payments of principal on insurance financing arrangements	(2,941)	(1,567)
Repayments of equipment loans	(154)	(187)
Repayments of capital lease obligations	(64)	(464)
Net cash provided by financing activities	991,319	240,593
Net increase (decrease) in cash, cash equivalents and restricted cash	285,470	(18,476)
Cash, cash equivalents and restricted cash at beginning of year	33,807	29,192
Cash, cash equivalents and restricted cash at end of period	319,277	10,716
Supplemental cash flow information:
Interest paid	(11,925)	(8,294)
Non-cash investing and financing activities:
Issuance of securities by Cano Health, Inc. in connection with acquisitions	60,000
Issuance of securities in PCIH in connection with acquisitions		34,300
Contingent Consideration In Connection With Acquisitions	9,600
Due to sellers in connection with acquisitions	295	16,288
Humana Affiliate Provider clinic leasehold improvements	2,864	1,025
Capital lease obligations entered into for property and equipment	52	482
Equipment loan obligations entered into for property and equipment	$ 183	103
Issuance of security in exchange for balance due to sellers		$ 2,158